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Abstract
Objective: To evaluate the use of liquid cytology in Pap smears in women with developmental disabilities (DD)
for endocervical cell yield and abnormalities, via speculum examination or blind technique.
Methods: We used retrospective chart review of gynecological visits by women with DD from October 2002 to
November 2005. Cervical cytology screening included speculum examination or blind technique. Endocervical
cell yield was analyzed via Pearson’s chi-square test.
Results: Of 240 attempted liquid cytology Pap smears, 199 (82.9%) were completed. Of these, 193 met inclu-
sion criteria for the study, and 120 (62.2%) contained endocervical cells. The endocervical cell yield with liquid
cytology/speculum was 80.0% and was 43.6% with liquid cytology/blind (p  0.001). Two blind smears (1.0%)
were abnormal; both revealed atypical squamous cells of undetermined significance (ASCUS) with subsequent
negative human papillomavirus (HPV) typing.
Conclusions: Cervical screening with liquid cytology in women with DD provides an overall rate of endocer-
vical cells of approximately 44%–80% depending on the technique used. Although this is much lower than in
the general population, this compares favorably with slide Pap smear in women with DD. The 44% yield of
endocervical cells and the finding of abnormal Pap smears with the blind technique suggest this is a reason-
able alternative for obtaining Pap smears in women with difficult pelvic examinations who otherwise would
not receive cervical screening.
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Introduction
GYNECOLOGICAL CARE IN WOMEN with developmental dis-abilities (DD) poses numerous challenges for the care-
giver as well as the patient. Obtaining an adequate menstrual
and sexual history is often difficult because of communica-
tion issues and lack of available historical data. Therefore,
the occurrence of past sexual activity may remain unclear in
this patient population. A pelvic examination, including a
Papanicolaou (Pap) smear, is often especially difficult due to
patient cooperation and physical handicaps.1
The Pap smear is an important tool for cervical screening
and has significantly reduced the incidence of and death
from cervical malignancies.2 Technology for cervical cytol-
ogy has greatly changed over the last decade, from the con-
ventional Slide Pap smear to the now commonly used liq-
uid-based cytology. The presence or absence of endocervical
cells determines the adequate sampling of the transforma-
tion zone and is, therefore, used in studies as an indicator of
successful sampling.3 Previous studies with slide Pap smear
showed that the cytobrush was more effective in the collec-
tion of endocervical cells (89%–99% yield) than was the cot-
ton swab (62%–87%).4–6 Liquid-based cytology has been
found to be as efficacious as,7 or superior to,8,9 slide Pap
smear for the diagnosis of cervical intraepithelial neoplasia
II–III (CIN II–III) and for decreasing the number of inade-
quate specimens.
There have been very few studies in the past addressing
cervical cytology in women in whom pelvic examinations
are difficult.10 All traditional techniques have been found to
be suboptimal, including a described nonspeculum blind
swab technique with a cotton tip, which had a very low yield
of endocervical cells but was often the only option in women
with a difficult pelvic examination.1,10
The primary aim of this study was to evaluate the use of
liquid cytology for cervical screening in women with DD.
We assessed the yield of endocervical cells and abnormal
Pap smears using liquid cytology Pap smears and compared
examination techniques (use of speculum vs. a blind swab
technique).
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Materials and Methods
A retrospective electronic chart review was performed of
clinic visits by women who attended a reproductive health
clinic that provides care exclusively for women with DD at
the University of Michigan from October 2002 to November
2005. All Pap smears were performed by an obstetrician-gy-
necologist, and no intravenous or oral sedation was admin-
istered. In October 2002, Pap smear technology was con-
verted to liquid cytology (ThinPrep, Cytyc Corporations,
Marlborough, MA). The study included all women 66 years
of age who underwent an attempted Pap smear with liquid
cytology at the clinic. Women with a prior hysterectomy
were excluded. The electronic charts were reviewed by a per-
son who was not involved in the gynecological care of these
patients. In reviewing each patient visit, a standardized clinic
visit form was created that included the patient’s age, level
of developmental delay, description of the pelvic examina-
tion, presence of an attempted Pap smear, and use and out-
comes of liquid-based cytology.
The level of developmental delay was noted as it was de-
scribed in the chart in the gynecology or other medical notes
(mild, moderate, severe, unable to determine from the chart).
The pelvic examination included use of a speculum or a blind
technique. The blind technique was used only in those
women who could not tolerate a speculum examination. This
technique consists of the advancement of one finger in the
vagina, palpating the cervical os, and sliding a cytobrush
over the finger to guide it to the cervical os in an effort to
obtain endocervical cells. If possible a spatula was also used;
however, this was rarely tolerated. All cervical cytology re-
sults were examined for the presence or absence of endo-
cervical cells, as well as cytological abnormalities.
Statistical analyses were performed via Pearson’s chi-
square tests on completed cervical cytology screening ex-
aminations. Although some patients had multiple revisits
and repeat examinations, each attempted Pap smear was
weighted equally, and the percentages of Pap smears that
contained endocervical cells were calculated. Confidence in-
tervals (CI) were not obtained, as not all the examinations
were statistically independent. Approval was obtained from
the Institutional Review Board of the University of Michigan
prior to conducting the study.
Results
From October 2002 to November 2005, there were 386
clinic visits by 186 women with DD who met study age cri-
teria, and 240 visits included a Pap smear or an attempted
Pap smear. The average age of the patients at the time of Pap
smear was 41.0 years, with a range of 17–65 years. In the 186
patients, the level of developmental delay was described as
severe in 67 (37.1%), moderate in 10 (5.4%), mild in 16 
(8.6%), and unreported in 91 (48.9%). 
Of the 240 Pap smears attempted, 199 (82.9%) were able
to be obtained, and 194 (80.8%) met criteria. One blind-ob-
tained specimen was acellular and was excluded from the
analysis; therefore, 193 Pap smears were studied. Of these,
120 (62.2%) contained endocervical cells. For a comparison
of those patients in whom a speculum could be used vs. those
in whom that was not possible (blind technique), the 193 Pap
smears were compared by technique: use of a speculum (n 
99) vs. the blind technique (n  94). This comparison dem-
onstrated that with liquid cytology, 79 (80.0%) of smears con-
tained endocervical cells when a speculum was used, and 41
(43.6%) contained endocervical cells when a blind technique
was used (chi-square  26.84, p  0.001) (Fig. 1). Two pa-
tients had abnormal Pap smears; both were classified as atyp-
ical squamous cells of undetermined significance (ASCUS),
with subsequent negative human papillomavirus (HPV) typ-
ing. Review of these cases shows that 1 patient had a nor-
mal follow-up, and 1 patient did not return for follow-up.
Discussion
Although there is difficulty in performing Pap smears for
women with DD, obtaining cervical cells for cancer screen-
ing was feasible in the majority of subjects (82.9%). The yield
of endocervical cells with liquid cytology ranged from 43.6%
with the blind technique to 80% for those who were able to
tolerate a speculum. Although these numbers are lower in
than the general population, they are statistically higher than
previously published rates with slide Pap smear tech-
niques.10 In this previous study,10 the slide Pap smear dem-
onstrated an overall yield of endocervical cells of 34%,
whereas the use of a speculum and the blind technique pro-
vided endocervical cells in 58% and 18% of Pap smears, re-
spectively.
The presence of endocervical cells has been used as a mea-
sure of quality or adequate sampling of the transformation
zone. There is controversy as to whether an endocervical cell
component is necessary to increase detection of cervical neo-
plasia, but it is still included in the Bethesda system to de-
scribe specimen adequacy.11,12 Therefore, we chose the pres-
ence of endocervical cells as our measure of adequate Pap
smear screen for this study. We find acceptable values of en-
docervical cells, improved over previous techniques, in our
population. These values are lower than in the general pop-
ulation, even with a speculum, because of the difficult ex-
aminations as a result of challenges with patient coopera-
tion, communication, and physical disabilities. From these
observations, we conclude that if a speculum cannot be used,
the blind technique with liquid cytology, although neither
ideal nor a replacement for the standard technique, may
yield endocervical cells and may identify abnormalities.
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FIG. 1. Comparison of endocervical cell yield with liquid
cytology, speculum vs. blind swab technique.
Examinations in women with DD are often helped by spe-
cial techniques. This may include a two-visit approach, with
the first visit to help the patient become comfortable with
the provider and the second for the actual examination. A
trusted caregiver present may help the patient relax. Stirrups
are seldom used, and a variety of positions may facilitate the
examinations, including the frog leg position, the side posi-
tion, or any position that does not abduct the legs signifi-
cantly. A long narrow Huffman speculum (adolescent specu-
lum) is advocated as opposed to a pediatric speculum, which
is too short for the adult vagina. Lidocaine gel on the in-
troitus has also been advocated by some.13 In the case of an
abnormal blind Pap smear, an examination under anesthe-
sia for colposcopy or treatment may be warranted.
Abnormal cytology findings accounted for 1.0% of Pap
smears in the present study and for 0.3% in a previous study
in this population.10 These percentages compare to an ab-
normal conventional Pap smear rate of 1.5%–21.9%14 and an
abnormal liquid cytology Pap smear rate of 21%–22% in the
general gynecological population.15 The presence of abnor-
mal cytology in women with DD is below the national preva-
lence, which has been reported as 2.3% in a study of 1,045,059
conventional samples.16 We suspect that most of our patients
are not often engaged in sexual activities, but it is difficult
to obtain a complete history because of communication is-
sues and record keeping of current and past sexual activity.
Unfortunately, the potential for being victims of sexual abuse
exists among these patients, thereby increasing the risk of
HPV infection. The actual incidence of abuse is difficult to
gauge; however, it has been reported as 13%–63% in previ-
ous studies.17–20
This study has several limitations. The retrospective na-
ture of this study is not ideal and may lead to bias; however,
the ability to perform a prospective study in this population
is limited because of difficulties with consent, continuity of
care, and follow-up. Another issue may be the age of our pa-
tients. As 13 of the women in our study were over the age
of 55 years, the postmenopausal regression of columnar ep-
ithelium upward into the endocervical canal may account
for the lack of endocervical cells in some samples.
When such issues as patient tolerance of examinations
and the infrequency of high-grade intraepithelial lesions
are considered, the question arises as to whether strict ad-
herence to cervical cytology screening recommendations is
necessary in women with developmental delay or whether
special guidelines could be established. Currently, the rec-
ommendations for cervical cytology screening among
women in the general population are applied to this spe-
cific patient population. The American College of Obstetri-
cians and Gynecologists (ACOG) and the American Cancer
Society (ACS) recommend that screening should begin ei-
ther 3 years after the initiation of intercourse or at age 21,
depending on which event occurs first.3,21 ACOG and ACS
recommendations include annual cervical cytology screen-
ing before the age of 30 and extension of the screening in-
terval to every 2–3 years in women aged 30 years pro-
vided they have had three consecutive negative Pap smears
and no history of CIN II or III, diethylstilbestrol exposure,
or an immunocompromised status, including infection with
HIV.3,21 The combination of negative cytology and nega-
tive HPV DNA testing has been reported to yield negative
predictive values of 99%–100%.22 Screening every 3 years
in women with such results could be beneficial in a popu-
lation such as those with DD. Whether blind screening with
HPV only will be helpful for this group of women will need
to be researched.
Clearly, the data currently available are not of sufficient
size to make predictions as to the optimal time interval for
cervical cancer screening in women with DD. However, the
relatively low number of abnormal Pap smears and the min-
imal level of pathology23 support not undertaking aggres-
sive screening, which may include anesthesia or sedation,
for this patient population for preventive healthcare. Future
studies need to address optimal screening intervals, the use
of HPV testing in women with DD, and the use of the HPV
vaccine.
Conclusions
Cervical screening with liquid cytology in women with
DD gives an overall rate of endocervical cells of approxi-
mately 44%–80% depending on the technique used. Al-
though this is much lower than in the general population,
this compares favorably with slide Pap smears in women
with DD. With a 44% yield of endocervical cells, although
less than ideal, the blind technique is a reasonable alterna-
tive for obtaining Pap smears in women with difficult pelvic
examinations who may otherwise get no cervical cancer
screening.
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